tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

EQRX

Revolution Medicines announces Horning joined board of directors
The FlyRevolution Medicines announces Horning joined board of directors
6M ago
EQRX
RVMD
Revolution Medicines completes acquisition of EQRx
PremiumThe Fly
Revolution Medicines completes acquisition of EQRx
6M ago
EQRX
RVMD
Revolution Medicines, EQRx stockholders approve EQRx acquisition
PremiumThe Fly
Revolution Medicines, EQRx stockholders approve EQRx acquisition
6M ago
EQRX
RVMD
Revolution Medicines says independent proxy recommend ‘FOR’ EQRx acquisition
PremiumThe Fly
Revolution Medicines says independent proxy recommend ‘FOR’ EQRx acquisition
6M ago
EQRX
RVMD
Revolution Medicines price target raised to $47 from $37 at Stifel
PremiumThe Fly
Revolution Medicines price target raised to $47 from $37 at Stifel
7M ago
EQRX
RVMD
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
8M ago
GNS
HYG
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
9M ago
HUT
SDC
Revolution Medicines price target raised to $40 from $35 at Oppenheimer
PremiumThe Fly
Revolution Medicines price target raised to $40 from $35 at Oppenheimer
9M ago
EQRX
RVMD
Revolution Medicines to acquire EQRx in all-stock transaction
PremiumThe Fly
Revolution Medicines to acquire EQRx in all-stock transaction
9M ago
EQRX
RVMD
Revolution Medicines to acquire EQRx in all-stock transaction
PremiumThe Fly
Revolution Medicines to acquire EQRx in all-stock transaction
9M ago
EQRX
RVMD
EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results
PremiumPress Releases
EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results
12M ago
EQRX
EQRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
EQRX Earnings this Week: How Will it Perform?
12M ago
EQRX
EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023
PremiumPress ReleasesEQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023
12M ago
EQRX
EQRx reports Q4 EPS (5c), consensus (20c)
PremiumThe Fly
EQRx reports Q4 EPS (5c), consensus (20c)
1y ago
EQRX
EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress
PremiumPress Releases
EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress
1y ago
EQRX
EQRx to Present at the 41st Annual J.P. Morgan Healthcare Conference
PremiumPress Releases
EQRx to Present at the 41st Annual J.P. Morgan Healthcare Conference
1y ago
EQRX
EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Sugemalimab in Metastatic Non-small Cell Lung Cancer
PremiumPress Releases
EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Sugemalimab in Metastatic Non-small Cell Lung Cancer
1y ago
EQRX
EQRx announces acceptance of MAA by EMA for sugemalimab in NSCLC
PremiumThe Fly
EQRx announces acceptance of MAA by EMA for sugemalimab in NSCLC
1y ago
EQRX
EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer
PremiumPress Releases
EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer
1y ago
EQRX
EQRx announces acceptance of MAA by EMA for aumolertinib
PremiumThe FlyEQRx announces acceptance of MAA by EMA for aumolertinib
1y ago
EQRX
EQRx downgraded to Underweight from Neutral at JPMorgan
PremiumThe Fly
EQRx downgraded to Underweight from Neutral at JPMorgan
1y ago
EQRX
EQRx to Participate in the Jefferies 2022 London Healthcare Conference
PremiumPress Releases
EQRx to Participate in the Jefferies 2022 London Healthcare Conference
1y ago
EQRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >